NVCR FY 2025 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$655M+8.3% YoY

Gross Profit

$488M74.5% margin

Operating Income

-$154M-23.5% margin

Net Income

-$136M-20.8% margin

EPS (Diluted)

$-1.22

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$76M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$804M

Total Liabilities

$464M

Stockholders' Equity

$340M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$655M	$605M	+8.3%
Gross Profit	$488M	$468M	+4.4%
Operating Income	-$154M	-$170M	+9.8%
Net Income	-$136M	-$169M	+19.2%